LMR Partners’s GeneDx Holdings Warrant WGSWW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.1K Hold
2,135,439
﹤0.01% 1354
2025
Q4
$101K Hold
2,135,439
﹤0.01% 1346
2025
Q3
$234K Buy
2,135,439
+100,000
+5% +$8.26K ﹤0.01% 1196
2025
Q2
$147K Buy
2,035,439
+302,634
+17% +$29.7K ﹤0.01% 1147
2025
Q1
$364K Buy
1,732,805
+200,000
+13% +$44.8K ﹤0.01% 974
2024
Q4
$245K Buy
+1,532,805
New +$264K ﹤0.01% 935
2024
Q3
Sell
-1,532,805
Closed -$53K 1542
2024
Q2
$45.5K Hold
1,532,805
﹤0.01% 933
2024
Q1
$84.3K Hold
1,532,805
﹤0.01% 935
2023
Q4
$15.3K Hold
1,532,805
﹤0.01% 846
2023
Q3
$45.8K Hold
1,532,805
﹤0.01% 732
2023
Q2
$15.8K Hold
1,532,805
﹤0.01% 745
2023
Q1
$559K Hold
1,532,805
0.01% 693
2022
Q4
$404K Hold
1,532,805
0.01% 905
2022
Q3
$1.34M Sell
1,532,805
-107,847
-7% -$30.3K 0.02% 643
2022
Q2
$2.07M Sell
1,640,652
-33,667
-2% -$13.7K 0.03% 512
2022
Q1
$5.14M Buy
1,674,319
+1,658,777
+10,673% +$1.15M 0.06% 309
2021
Q4
$69K Hold
15,542
﹤0.01% 1122
2021
Q3
$118K Buy
15,542
+100
+0.6% +$329 ﹤0.01% 954
2021
Q2
$71K Buy
+15,442
New +$66.1K ﹤0.01% 930

Other funds holding WGSWW

LMR Partners's WGSWW Position: Q1 2026 in Review

LMR Partners held its GeneDx Holdings Warrant (WGSWW) position steady in Q1 2026 at 2,135,439 shares worth $17.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1354.

LMR Partners first reported a position in WGSWW in Q2 2021 and has held it in 19 quarters since. The position peaked at $5.14M in Q1 2022. 13 funds tracked by Wall St. Rank hold WGSWW as of Q1 2026.

  • LMR Partners held 2,135,439 shares of GeneDx Holdings Warrant worth $17.1K as of Q1 2026.
  • LMR Partners left its GeneDx Holdings Warrant share count unchanged in Q1 2026.
  • GeneDx Holdings Warrant made up ﹤0.01% of LMR Partners's portfolio in Q1 2026, its #1354 holding.
  • LMR Partners first reported a position in GeneDx Holdings Warrant in Q2 2021 and has held it in 19 quarters since.
  • LMR Partners's GeneDx Holdings Warrant position peaked at $5.14M in Q1 2022.
  • 13 funds tracked by Wall St. Rank held GeneDx Holdings Warrant as of Q1 2026.

Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.